March 29, 2018
Nichi-Iko President Yuichi Tamura (left), Eisai CEO Haruo Naito Eisai will bow out of the generic supply business by transferring the entire stake in its wholly owned subsidiary, Elmed Eisai, to leading Japanese generic maker Nichi-Iko Pharmaceutical for roughly 17.12...read more